NEWS

News Articles

GeoVax Announces Publication of Lassa Fever Vaccine Study Results

September 4, 2019

100% Single-Dose Protection Observed in Lethal Challenge Model ATLANTA, GA, September 4, 2019 – GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, today announced publication of its article entitled “A Single Dose of Modified Vaccinia Ankara Expressing Lassa Virus-like Particles Protects Mice from Lethal Intra-cerebral Virus Challenge.” The paper appears in the open…

Read More

Thank you, Senator Isakson for Supporting Innovation

September 3, 2019

Biotech will lose a champion in Washington. Sen. Johnny Isakson (R-GA), who received BIO’s Innovator in Biotech Award in April (pictured), and is a 2018 recipient of Georgia Bio’s Legislator of the Year award last week announced he will retire at the end of the year due to health issues. We wish him all the best and…

Read More

U.S. Sen. Johnny Isakson to retire early due to Parkinson’s

August 28, 2019

U.S. Sen. Johnny Isakson, R-Ga., announced Wednesday he will leave office early due to a battle with Parkinson’s disease.  Isakson, 74, will resign on Dec. 31 after more than 40 years in elective office at the state and federal levels.  “I am leaving a job I love because my health challenges are taking their toll on…

Read More

Lt. Gov. Duncan names health-care task force

August 28, 2019

Lt. Gov. Geoff Duncan named a task force Wednesday that will look for ways to improve Georgians’ access to quality health care while reducing costs. Duncan will chair the 16-member panel, which will include members of the state Senate as well as health-care executives and academics specializing in medical subjects. As lieutenant governor, Duncan serves as president…

Read More

Piedmont Healthcare joins nonprofit generic drug company Civica

August 15, 2019

Piedmont Healthcare has joined Civica, a new nonprofit generic drug company with a goal of reducing chronic drug shortages in the United States, Piedmont announced Thursday. Launched last year, Civica supplies its members at least 14 drugs commonly used by hospitals in emergency care, surgery, pain management and in treating hypertension. More recently, Civica announced…

Read More

Alimera Announces ILUVIEN® Regulatory Approval in Australia for the Treatment of Diabetic Macular Edema

August 5, 2019

Aug 5, 2019 Specialised Therapeutics, an Australian biopharmaceutical company and Alimera’s distribution partner, to next seek national reimbursement ATLANTA, Aug. 05, 2019 (GLOBE NEWSWIRE) — Alimera Sciences, Inc. (Nasdaq: ALIM) (“Alimera”), a leader in the commercialization and development of prescription ophthalmology treatments for the management of retinal diseases, announces today that the Australian Therapeutic Goods Administration (TGA), the division of the Australian…

Read More